Clinicians and health system leaders met in Cleveland, Ohio, on October 23, 2025, to share improvements to value-based care ...

Researchers revealed that the microbial metabolite TMA can directly block the immune protein IRAK4, reducing inflammation and ...

Drugs like semaglutide, liraglutide, and tirzepatide—known as GLP-1 receptor agonists—are commonly used to help manage type 2 ...

Tantalizing results from small trials and anecdotes raised hopes that drugs like Ozempic could help. Despite setbacks, ...

Among individuals in Sweden receiving second-generation drug-eluting stents, those with diabetes, particularly type 1 ...

A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) ...

‘World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults’ by Francesca Celletti et al. was published in JAMA at 13:45 ...

Richard EleshoIn spite of its global devastation on humanity, diabetes mellitus is not a death sentence as those living with the disease stand a good chance of survival if they adopt the right ...

Novo Nordisk announced Monday it is lowering costs for weight loss and diabetes drugs, weeks after it struck a deal with the Trump administration to drop prices for customers. The Wegovy 0.25 ...

Maryland’s Prescription Drug Affordability Board voted Monday to restrict the price that state and local employees will have to pay for two medicines for type 2 diabetes, Jaridance and Farxiga. The ...

Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and ...

A common diabetes drug could dampen some of the key benefits of exercise, a new study has found. Researchers from Rutgers University discovered that adults who took metformin, a widely used generic ...